Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Der Jeught, Kevin" or (type any "bookEditor issueEditor" and editor="Van Der Jeught, ...

Add to list
ST2 as checkpoint target for colorectal cancer immunotherapy

Kevin Van der Jeught, Yifan Sun, Yuanzhang Fang, Zhuolong Zhou, Hua Jiang, Tao Yu, Jinfeng Yang, Malgorzata M. Kamocka, Ka Man So, Yujing Li, et al.

(2020) JCI INSIGHT. 5(9).
Add to list
Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte (UGent) , et al.

(2018) ACS NANO. 12(10). p.9815-9829
Add to list
Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Ahmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, Kevin Van der Jeught, Serge Muyldermans, José Van Der Heyden (UGent) , Tony Lahoutte, Jan Tavernier (UGent) and Nick Devoogdt

(2017) MOLECULAR CANCER THERAPEUTICS. 16(12). p.2828-2839
Add to list
- Journal Article
- A1
Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Sandra Van Lint (UGent) , Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Dufour, Kevin Van Der Jeught, Lukasz Bialkowski, et al.

(2016) CANCER IMMUNOLOGY RESEARCH. 4(2). p.146-156
Add to list
- Journal Article
- A1
Intratumoral delivery of mRNA : overcoming obstacles for effective immunotherapy

Kevin Van Der Jeught, Sandra Van Lint (UGent) , Kris Thielemans and Karine Breckpot

(2015) ONCOIMMUNOLOGY. 4(5).
Add to list
- Journal Article
- A1
- open access
Targeting the tumor microenvironment to enhance antitumor immune responses

Kevin Van Der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, Katrijn Broos, Cleo Goyvaerts, Dries Renmans, Sandra Van Lint (UGent) , Carlo Heirman, Kris Thielemans and Karine Breckpot

(2015) ONCOTARGET. 6(3). p.1359-1381

Academic Bibliography

ST2 as checkpoint target for colorectal cancer immunotherapy

Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety

Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma

Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Intratumoral delivery of mRNA : overcoming obstacles for effective immunotherapy

Targeting the tumor microenvironment to enhance antitumor immune responses

Contents

Support

Contact